Original Articles

How Much Digital Rectal Examination is Valuable for the Decision of Biopsy in Patients with PSA ≤4 ng/ml?
  • Özgü Aydoğdu
  • İbrahim Halil Bozkurt
  • Tarık Yonguç
  • Tansu Değirmenci
  • Salih Polat
  • Bülent Günlüsoy
  • İbrahim Küçüktürkmen
  • Yasin Ceylan
  • Süleyman Minareci
Bull Urooncol 2015; 14: 1-4 DOI: 10.4274/uob.253
The Importance of Multiparametric Magnetic Resonance Imaging on Prostate Cancer Diagnosis
  • Nurullah Hamidi
  • Evren Süer
  • Eriz Özden
  • Aykut Akıncı
  • Mehmet İlker Gökçe
  • Onur Telli
  • Ömer Gülpınar
  • Çağatay Göğüs
  • Kadir Türkölmez
  • Sümer Baltacı
Bull Urooncol 2016; 15: 4-7 DOI: 10.4274/uob.385
Do the Pain Scores During Transrectal Ultrasound-guided Prostate Rebiopsy Change in Patients with a Prior History of Prostate Biopsy?
  • Dr. Deniz Bolat
  • Dr. Mehmet Erhan Aydın
  • Dr. Bülent Günlüsoy
  • Dr. Tansu Değirmenci
  • Dr. Yusuf Kadir Topçu
  • Dr. İbrahim Küçüktürkmen
  • Dr. Zafer Kozacıoğlu
Bull Urooncol 2017; 16: 4-7 DOI: 10.4274/uob.784
Clinical Significance of Perineural Invasion in Prostate Needle Biopsy in Patients Diagnosed with Extraprostatic Extension and Seminal Vesicle Invasion after Radical Prostatectomy
  • Ozan Bozkurt
  • Serdar Çelik
  • Ömer Demir
  • Özgür Gürboğa
  • Burçin Tuna
  • Kutsal Yörükoğlu
  • Güven Aslan
Bull Urooncol 2015; 14: 5-7 DOI: 10.4274/uob.274
The Optimum Dosage of Prilocaine in Periprostatic Nerve Block During Transrectal Ultrasound Guided Prostate Biopsy: A New Approach in Dose Calculation
  • Umut Gönülalan
  • Murat Koşan
  • Enis Kervancıoğlu
  • Tufan Çiçek
  • Bülent Öztürk
  • Hakan Özkardeş
Bull Urooncol 2016; 15: 13-17 DOI: 10.4274/uob.525
Initial Outcomes and Assessment of the Transperineal Multiparametric-Magnetic Resonance Imaging/Ultrasonography Fusion Biopsy Method in Diagnosing Clinically-significant Prostate Cancer
  • Mahir B. Özgen
  • Bora Özveren
  • Sertaç Uzel
  • Uğur Altuğ
  • Levent Türkeri
Bull Urooncol 2017; 16: 42-45 DOI: 10.4274/uob.805
Association between Hormonal Evaluation Before Prostate Needle Biopsy and Locally Advanced Prostate Cancer
  • Serdar Çelik
  • Ozan Bozkurt
  • Hüseyin Alperen Yıldız
  • Ömer Demir
  • Burçin Tuna
  • Kutsal Yörükoğlu
  • Güven Aslan
Bull Urooncol 2016; 15: 52-56 DOI: 10.4274/uob.638
Rebiopsy Results of the Patients in Which the First Biopsy Revealed High Grade Prostatic Intraepithelial Neoplasia
  • Şakir Ongün
  • Ozan Bozkurt
  • Kaan Çömez
  • Ömer Demir
  • Güven Aslan
  • Burçin Tuna
  • Kutsal Yörükoğlu
  • İlhan Çelebi
Bull Urooncol 2016; 15: 57-60 DOI: 10.4274/uob.630
Is Prostate Specific Antigen Density more Important than in the Diagnosis of Prostate Cancer in Patients with a Total Prostate Specific Antigen Value <10 ng/mL?
  • Soner Çoban
  • Muhammet Güzelsoy
  • Ali Rıza Türkoğlu
  • Ünal Kurtoğlu
  • Dursun Ünal
  • Noyan Can Akdur
  • Sedat Öner
  • Murat Demirbaş
Bull Urooncol 2015; 14: 83-87 DOI: 10.4274/uob.268
Evaluation of the Relationship between Pathology Results and Pain Scores in Patients Who Underwent Transrectal Ultrasound-Guided Prostate
  • Deniz Bolat
  • Mehmet Erhan Aydın
  • Bülent Günlüsoy
  • Tansu Değirmenci
  • Yusuf Kadir Topçu
  • İbrahim Küçüktürkmen
  • Yasin Ceylan
  • Ertuğrul Şefik
Bull Urooncol 2016; 15: 86-89 DOI: 10.4274/uob.666
Significance of Pretreatment Testosterone Levels in Prostate Cancer Risk Groups
  • Serdar Çelik
  • Ozan Bozkurt
  • Hüseyin Alperen Yıldız
  • Ömer Demir
  • Burçin Tuna
  • Kutsal Yörükoğlu
  • Güven Aslan
Bull Urooncol 2016; 15: 98-102 DOI: 10.4274/uob.699
Preoperative Factors Related to Stage and Grade Increase in D’Amico Low-Risk and Intermediate-Risk Group Patients
  • Serdar Çelik
  • Ozan Bozkurt
  • Ömer Demir
  • Burçin Tuna
  • Kutsal Yörükoğlu
  • Güven Aslan
Bull Urooncol 2016; 15: 148-153 DOI: 10.4274/uob.738

Review

Biopsy of renal mass: The past, present and the future
  • Tünkut Doğanca
  • Can Öbek
Bull Urooncol 2011; 10: 16-20
Sentinel Lymph Node Biopsy in Lymphadenectomy for Prostate Cancer
  • Cenk Acar
  • Henk van der Poel
Bull Urooncol 2016; 15: 69-75 DOI: 10.4274/uob.625
Magnetic Resonance - Transrectal Ultrasound Fusion Guided Prostate Biopsy
  • Ömer Burak Argun
  • Can Öbek
  • Ali Rıza Kural
Bull Urooncol 2016; 15: 76-79 DOI: 10.4274/uob.635
What is the best cutoff value of PSA in detection of prostate cancer
  • Hakan Gemalmaz
Bull Urooncol 2012; 11: 92-95
What is the Approach to Negative Prostate Biopsies?
  • Bora İrer
  • Güven Aslan
Bull Urooncol 2015; 14: 94-96 DOI: 10.4274/uob.310
Repeat prostate biopsy: who, when, how?
  • Hayrettin Şahin
Bull Urooncol 2012; 11: 103-107
Current status of pain control in trus-guided prostate biopsy
  • İlker Seçkiner
  • Ömer Bayrak
Bull Urooncol 2012; 11: 108-113
Prostate Biopsy 2014: TRUS, MRI/TRUS Fusion? Transrectal? Transperineal?
  • Kaan Çömez
  • Ozan Bozkurt
  • Mehmet Uğur Mungan
Bull Urooncol 2015; 14: 128-135 DOI: 10.4274/uob.329
Percutaneous Needle Biopsy of Small Renal Masses
  • Özgür Yaycığolu
  • Mehmet Vehbi Kayra
Bull Urooncol 2014; 13: 161-164 DOI: 10.4274/uob.117
Liquid Biopsy: Circulating Tumor Cells and its Impact on Follow-up/Treatment of Prostate Cancer Patients
  • İbrahim Kulaç
Bull Urooncol 2014; 13: 196-200 DOI: 10.4274/uob.159

Case Report

Incidental Amyloidosis of the Seminal Vesicle: A Case Report and Review of the Literature
  • Deniz Bolat
  • Salih Polat
  • Tamer Şahin
  • Bülent Günlüsoy
  • Tansu Değirmenci
  • Zafer Kozacıoğlu
  • Süleyman Minareci
  • Sait Şen
Bull Urooncol 2016; 15: 41-43 DOI: 10.4274/uob.564